NF Trinity Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$15.9M Hold
108,448
2.54% 11
2018
Q4
$14.5M Hold
108,448
2.36% 10
2018
Q3
$20.7M Sell
108,448
-17,000
-14% -$3.12M 2.73% 9
2018
Q2
$20.9M Hold
125,448
2.86% 9
2018
Q1
$21.1M Hold
125,448
2.91% 8
2017
Q4
$20.5M Buy
125,448
+16,000
+15% +$2.87M 2.67% 10
2017
Q3
$22.4M Buy
109,448
+13,800
+14% +$3.21M 3.2% 9
2017
Q2
$23.3M Sell
95,648
-12,500
-12% -$2.94M 3.3% 10
2017
Q1
$25.8M Sell
108,148
-13,000
-11% -$3.03M 3.5% 11
2016
Q4
$25.4M Hold
121,148
3.57% 12
2016
Q3
$27.9M Hold
121,148
3.11% 10
2016
Q2
$28M Buy
121,148
+13,043
+12% +$3.01M 3.07% 11
2016
Q1
$29M Hold
108,105
3.51% 8
2015
Q4
$33.8M Buy
+108,105
New +$32.2M 3.84% 8

Other funds holding AGN

NF Trinity Capital's AGN Position: Q1 2019 in Review

NF Trinity Capital held its Allergan plc (AGN) position steady in Q1 2019 at 108,448 shares worth $15.9M. The position accounts for 2.54% of the portfolio, ranked #11.

NF Trinity Capital first reported a position in AGN in Q4 2015 and has held it in 14 quarters since. The position peaked at $33.8M in Q4 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • NF Trinity Capital held 108,448 shares of Allergan plc worth $15.9M as of Q1 2019.
  • NF Trinity Capital left its Allergan plc share count unchanged in Q1 2019.
  • Allergan plc made up 2.54% of NF Trinity Capital's portfolio in Q1 2019, its #11 holding.
  • NF Trinity Capital first reported a position in Allergan plc in Q4 2015 and has held it in 14 quarters since.
  • NF Trinity Capital's Allergan plc position peaked at $33.8M in Q4 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on NF Trinity Capital's 13F filing for Q1 2019, filed 10 May 2019.